Z-1523-2021 Class II Ongoing

Recalled by Medtronic Inc., Cardiac Rhythm And Heart Failure (CRHF) — Mounds View, MN

FDA device recall Z-1523-2021 was initiated by Medtronic Inc., Cardiac Rhythm And Heart Failure (CRHF) on Apr 6, 2021 and is designated Class II. Reason for recall: There is a SmartSync software issue that results in an overestimation in the displayed longevity of these devices during an approximate 6-month window of time before the device triggers its… The recall status is ongoing. Affected quantity: 45,411 devices.

Recall details

Product Type
Devices
Report Date
May 12, 2021
Initiation Date
Apr 6, 2021
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
45,411 devices

Product description

CRT-P Quad Models (CRT-Ps): a. Percepta CRT-P MRI: W1TR01, W1TR04, W4TR01, W4TR04 b. Serena CRT-P MRI: W1TR02, W1TR05, W4TR02, W4TR05 c. Solara CRT-P MRI: W1TR03, W1TR06, W4TR03, W4TR06. implantable medical devices used to treat arrhythmias related to bradycardia, and cardiac resynchronization therapy (CRT)

Reason for recall

There is a SmartSync software issue that results in an overestimation in the displayed longevity of these devices during an approximate 6-month window of time before the device triggers its Recommended Replacement Time (RRT).

Distribution pattern

Worldwide

Code information

all serial numbers

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-1523-2021
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for Z-1523-2021. Report a data issue: hello@regdatalab.com.